These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 27631626)

  • 1. Differentiation between Glioblastoma Multiforme and Primary Cerebral Lymphoma: Additional Benefits of Quantitative Diffusion-Weighted MR Imaging.
    Ko CC; Tai MH; Li CF; Chen TY; Chen JH; Shu G; Kuo YT; Lee YC
    PLoS One; 2016; 11(9):e0162565. PubMed ID: 27631626
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative apparent diffusion coefficients in the characterization of brain tumors and associated peritumoral edema.
    Server A; Kulle B; Maehlen J; Josefsen R; Schellhorn T; Kumar T; Langberg CW; Nakstad PH
    Acta Radiol; 2009 Jul; 50(6):682-9. PubMed ID: 19449234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Measurements of diagnostic examination performance using quantitative apparent diffusion coefficient and proton MR spectroscopic imaging in the preoperative evaluation of tumor grade in cerebral gliomas.
    Server A; Kulle B; Gadmar ØB; Josefsen R; Kumar T; Nakstad PH
    Eur J Radiol; 2011 Nov; 80(2):462-70. PubMed ID: 20708868
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differentiation of glioblastoma multiforme, metastases and primary central nervous system lymphomas using multiparametric perfusion and diffusion MR imaging of a tumor core and a peritumoral zone-Searching for a practical approach.
    Neska-Matuszewska M; Bladowska J; Sąsiadek M; Zimny A
    PLoS One; 2018; 13(1):e0191341. PubMed ID: 29342201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic value of peritumoral minimum apparent diffusion coefficient for differentiation of glioblastoma multiforme from solitary metastatic lesions.
    Lee EJ; terBrugge K; Mikulis D; Choi DS; Bae JM; Lee SK; Moon SY
    AJR Am J Roentgenol; 2011 Jan; 196(1):71-6. PubMed ID: 21178049
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary cerebral lymphoma and glioblastoma multiforme: differences in diffusion characteristics evaluated with diffusion tensor imaging.
    Toh CH; Castillo M; Wong AM; Wei KC; Wong HF; Ng SH; Wan YL
    AJNR Am J Neuroradiol; 2008 Mar; 29(3):471-5. PubMed ID: 18065516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Perfusion and diffusion MR imaging in enhancing malignant cerebral tumors.
    Calli C; Kitis O; Yunten N; Yurtseven T; Islekel S; Akalin T
    Eur J Radiol; 2006 Jun; 58(3):394-403. PubMed ID: 16527438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does adding FDG-PET to MRI improve the differentiation between primary cerebral lymphoma and glioblastoma? Observer performance study.
    Makino K; Hirai T; Nakamura H; Murakami R; Kitajima M; Shigematsu Y; Nakashima R; Shiraishi S; Uetani H; Iwashita K; Akter M; Yamashita Y; Kuratsu J
    Ann Nucl Med; 2011 Jul; 25(6):432-8. PubMed ID: 21404136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gradient of apparent diffusion coefficient values in peritumoral edema helps in differentiation of glioblastoma from solitary metastatic lesions.
    Lemercier P; Paz Maya S; Patrie JT; Flors L; Leiva-Salinas C
    AJR Am J Roentgenol; 2014 Jul; 203(1):163-9. PubMed ID: 24951211
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Potential Role of Peritumoral Apparent Diffusion Coefficient Evaluation in Differentiating Glioblastoma and Solitary Metastatic Lesions of the Brain.
    Tepe M; Saylisoy S; Toprak U; Inan I
    Curr Med Imaging; 2021; 17(10):1200-1208. PubMed ID: 33726654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nonenhancing peritumoral hyperintense lesion on diffusion-weighted imaging in glioblastoma: a novel diagnostic and specific prognostic indicator.
    Kolakshyapati M; Adhikari RB; Karlowee V; Takayasu T; Nosaka R; Amatya VJ; Takeshima Y; Akiyama Y; Sugiyama K; Kurisu K; Yamasaki F
    J Neurosurg; 2018 Mar; 128(3):667-678. PubMed ID: 28362236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Accuracy of apparent diffusion coefficients and enhancement ratios on magnetic resonance imaging in differentiating primary cerebral lymphomas from glioblastoma.
    Anwar SSM; Baig MZ; Laghari AA; Mubarak F; Shamim MS; Jilani UA; Khalid MU
    Neuroradiol J; 2019 Oct; 32(5):328-334. PubMed ID: 31188064
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiparametric imaging-based differentiation of lymphoma and glioblastoma: using T1-perfusion, diffusion, and susceptibility-weighted MRI.
    Saini J; Kumar Gupta P; Awasthi A; Pandey CM; Singh A; Patir R; Ahlawat S; Sadashiva N; Mahadevan A; Kumar Gupta R
    Clin Radiol; 2018 Nov; 73(11):986.e7-986.e15. PubMed ID: 30197047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary central nervous system lymphoma and atypical glioblastoma: differentiation using the initial area under the curve derived from dynamic contrast-enhanced MR and the apparent diffusion coefficient.
    Choi YS; Lee HJ; Ahn SS; Chang JH; Kang SG; Kim EH; Kim SH; Lee SK
    Eur Radiol; 2017 Apr; 27(4):1344-1351. PubMed ID: 27436023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glioblastoma multiforme with diffusion-weighted magnetic resonance imaging characteristics mimicking primary brain lymphoma. Case report.
    Toh CH; Chen YL; Hsieh TC; Jung SM; Wong HF; Ng SH
    J Neurosurg; 2006 Jul; 105(1):132-5. PubMed ID: 16871888
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Value of Minimum Apparent Diffusion Coefficient in Peritumoral Edema in the Differential Diagnosis between Primary Central Nervous System Lymphoma and Glioblastoma].
    Li MG; Chen ZY; Liu G; Xiao HF; Chen XJ; Lou X; Ma L
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2018 Apr; 40(2):146-150. PubMed ID: 29724302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differentiation of solitary brain metastasis from glioblastoma multiforme: a predictive multiparametric approach using combined MR diffusion and perfusion.
    Bauer AH; Erly W; Moser FG; Maya M; Nael K
    Neuroradiology; 2015 Jul; 57(7):697-703. PubMed ID: 25845813
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative Evaluation of Diffusion and Dynamic Contrast-Enhanced Magnetic Resonance Imaging for Differentiation Between Primary Central Nervous System Lymphoma and Glioblastoma.
    Lu S; Wang S; Gao Q; Zhou M; Li Y; Cao P; Hong X; Shi H
    J Comput Assist Tomogr; 2017; 41(6):898-903. PubMed ID: 28806317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lymphomas and glioblastomas: differences in the apparent diffusion coefficient evaluated with high b-value diffusion-weighted magnetic resonance imaging at 3T.
    Doskaliyev A; Yamasaki F; Ohtaki M; Kajiwara Y; Takeshima Y; Watanabe Y; Takayasu T; Amatya VJ; Akiyama Y; Sugiyama K; Kurisu K
    Eur J Radiol; 2012 Feb; 81(2):339-44. PubMed ID: 21129872
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differentiating between Glioblastoma and Primary CNS Lymphoma Using Combined Whole-tumor Histogram Analysis of the Normalized Cerebral Blood Volume and the Apparent Diffusion Coefficient.
    Bao S; Watanabe Y; Takahashi H; Tanaka H; Arisawa A; Matsuo C; Wu R; Fujimoto Y; Tomiyama N
    Magn Reson Med Sci; 2019 Jan; 18(1):53-61. PubMed ID: 29848919
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.